| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ca8b43bbdb5ffa184c596e2b5275883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e222b05011886d07ff6617418f84aa02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b564357d5d2a41a2d3094e135b8333a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43b663ec2277361e7a2ffa2e5984a8f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5c56910bebf40fe6b00041b80b8caf6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18 |
| filingDate |
2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826d2f20ec414292d6d7ae6518ee95ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_065a5fe2c80c4e5e5f7920b1a86d8730
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cbd58aa9a88597914fbbc89503c5a9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c10f230ba206dce01cf88d9c81aa551 |
| publicationDate |
2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006081293-A2 |
| titleOfInvention |
Delivery of bio-available compounds with anhydrous topical preparations |
| abstract |
The disclosed systems and methods for delivery of bio-available compounds in topical preparations generally include anhydrous carrier particles adapted to carry bio-available compounds. The carrier particles may be admixed with anhydrous formulation material that is suitably adapted to suspend and/or separate the carrier particles. Disclosed features and specifications may be variously controlled, adapted or otherwise optionally modified to realize improved production and/or use of carrier particles that may be employed to deliver bio-available compounds in order to achieve a desired purpose. Exemplary embodiments of the present invention generally provide anhydrous carrier particles that may be mixed with substantially anhydrous topical preparations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-202000011746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3912617-A1 |
| priorityDate |
2005-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |